[Drug induced obesity].
Murakami
T
T
Institute of Medical Science, School of Medicine, St. Marianna University.
Mizushima
Y
Y
D000305:Adrenal Cortex Hormones / Q000009:adverse effects*; D000319:Adrenergic beta-Antagonists / Q000009:adverse effects; D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects; D005260:Female; D012739:Gonadal Steroid Hormones / Q000009:adverse effects*; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D008297:Male; D008535:Megestrol / Q000009:adverse effects / Q000031:analogs & derivatives; D019290:Megestrol Acetate; D009765:Obesity / Q000139:chemically induced*; D011619:Psychotropic Drugs / Q000009:adverse effects*; D013629:Tamoxifen / Q000009:adverse effects
D000305:Adrenal Cortex Hormones; D000319:Adrenergic beta-Antagonists; D018931:Antineoplastic Agents, Hormonal; D012739:Gonadal Steroid Hormones; D007004:Hypoglycemic Agents; D011619:Psychotropic Drugs; D013629:Tamoxifen; D008535:Megestrol; D019290:Megestrol Acetate